These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2704060)
61. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration. Huupponen R; Paija O; Salonen M; Björklund H; Rouru J; Anttila M Drugs R D; 2003; 4(6):339-45. PubMed ID: 14584962 [TBL] [Abstract][Full Text] [Related]
62. Single-dose pharmacokinetics of the trypanosomicide benznidazole in man. Raaflaub J; Ziegler WH Arzneimittelforschung; 1979; 29(10):1611-4. PubMed ID: 583230 [TBL] [Abstract][Full Text] [Related]
63. Pharmacodynamic profile of verapamil in relation to absolute bioavailability: investigations with a conventional and a controlled-release formulation. Harder S; Thürmann P; Siewert M; Blume H; Huber T; Rietbrock N J Cardiovasc Pharmacol; 1991 Feb; 17(2):207-12. PubMed ID: 1709224 [TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetic properties of noscapine. Dahlström B; Mellstrand T; Löfdahl CG; Johansson M Eur J Clin Pharmacol; 1982; 22(6):535-9. PubMed ID: 7128665 [TBL] [Abstract][Full Text] [Related]
65. Influence of food intake on the bioavailability of urapidil in healthy volunteers. Kirsten R; Nelson K; Molz KH; Gielsdorf W; Haerlin R Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):298-301. PubMed ID: 2737799 [TBL] [Abstract][Full Text] [Related]
66. Ronidazole in high concentrations in drinking water for treatment and prevention of diarrhea in swine dysentery. Olson LD; Rodabaugh DE Am J Vet Res; 1976 Jul; 37(7):757-61. PubMed ID: 937799 [TBL] [Abstract][Full Text] [Related]
67. Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet. Jonkman JH; Berg WC; de Vries K; de Zeeuw RA; Schoenmaker R; Grimberg N Eur J Clin Pharmacol; 1981; 21(1):39-44. PubMed ID: 7333345 [TBL] [Abstract][Full Text] [Related]
68. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs. Bach JE; Kukanich B; Papich MG; McKiernan BC J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856 [TBL] [Abstract][Full Text] [Related]
69. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941 [TBL] [Abstract][Full Text] [Related]
70. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers. Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748 [TBL] [Abstract][Full Text] [Related]
71. [Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate]. Muck B; Bonn R; Rietbrock N Arzneimittelforschung; 1989 Oct; 39(10):1274-6. PubMed ID: 2610720 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics of buspirone extended-release tablets: a single-dose study. Sakr A; Andheria M J Clin Pharmacol; 2001 Jul; 41(7):783-9. PubMed ID: 11452712 [TBL] [Abstract][Full Text] [Related]
73. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
74. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers. Popović J; Mitić R; Sabo A; Mikov M; Jakovljević V; Daković-Svajcer K Eur J Drug Metab Pharmacokinet; 2006; 31(2):87-96. PubMed ID: 16898076 [TBL] [Abstract][Full Text] [Related]
75. Pharmacokinetics of ebrotidine in rats and dogs. Albet C; Pérez JA; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):483-5. PubMed ID: 9205748 [TBL] [Abstract][Full Text] [Related]
76. Disposition kinetics, bioavailability and renal clearance of cefepime in calves. Ismail MM Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293 [TBL] [Abstract][Full Text] [Related]
77. Pharmacokinetics of enprofylline administered intravenously and as a sustained-release tablet at steady state in children with asthma. Watson WT; Simons KJ; Simons FE J Pediatr; 1988 Apr; 112(4):658-62. PubMed ID: 3351694 [TBL] [Abstract][Full Text] [Related]
78. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration. Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879 [TBL] [Abstract][Full Text] [Related]
79. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation. Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538 [TBL] [Abstract][Full Text] [Related]
80. Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations. Assinder DF; Chasseaud LF; Taylor T J Pharm Sci; 1977 Jun; 66(6):775-8. PubMed ID: 577507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]